TR199900548A3 - Düsük kesme kuvvetli taneleme kullanilarak dozaj birimlerinin yapimi. - Google Patents

Düsük kesme kuvvetli taneleme kullanilarak dozaj birimlerinin yapimi.

Info

Publication number
TR199900548A3
TR199900548A3 TR1999/00548A TR9900548A TR199900548A3 TR 199900548 A3 TR199900548 A3 TR 199900548A3 TR 1999/00548 A TR1999/00548 A TR 1999/00548A TR 9900548 A TR9900548 A TR 9900548A TR 199900548 A3 TR199900548 A3 TR 199900548A3
Authority
TR
Turkey
Prior art keywords
production
dosage units
low shear
shear granulation
granulation
Prior art date
Application number
TR1999/00548A
Other languages
English (en)
Other versions
TR199900548A2 (tr
Inventor
Vromans Herman
Gerardina Maria Poels-Janssen Hendrika
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of TR199900548A3 publication Critical patent/TR199900548A3/tr
Publication of TR199900548A2 publication Critical patent/TR199900548A2/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
TR1999/00548A 1998-03-12 1999-03-12 Düsük kesme kuvvetli taneleme kullanilarak dozaj birimlerinin yapimi. TR199900548A2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98200790 1998-03-12

Publications (2)

Publication Number Publication Date
TR199900548A3 true TR199900548A3 (tr) 1999-10-21
TR199900548A2 TR199900548A2 (tr) 1999-10-21

Family

ID=8233460

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/00548A TR199900548A2 (tr) 1998-03-12 1999-03-12 Düsük kesme kuvvetli taneleme kullanilarak dozaj birimlerinin yapimi.

Country Status (15)

Country Link
US (1) US6054145A (tr)
JP (1) JPH11319035A (tr)
KR (1) KR19990077775A (tr)
CN (1) CN1238948A (tr)
AR (1) AR016454A1 (tr)
AU (1) AU2118199A (tr)
BR (1) BR9904552A (tr)
CA (1) CA2265211A1 (tr)
CZ (1) CZ88899A3 (tr)
HU (1) HUP9900598A2 (tr)
IL (1) IL128818A0 (tr)
NO (1) NO991195L (tr)
PL (1) PL331961A1 (tr)
SG (1) SG72938A1 (tr)
TR (1) TR199900548A2 (tr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1177726A1 (en) * 2000-08-04 2002-02-06 Aventis Animal Nutrition S.A. Process for the production of granules of methionine
JP2002326925A (ja) * 2001-04-27 2002-11-15 Asahi Breweries Ltd 造粒物および錠剤の製造方法
DK1670440T3 (da) * 2003-09-29 2014-07-07 Novo Nordisk As HRT formuleringer
ES2933479T3 (es) * 2003-09-29 2023-02-09 Novo Nordisk Healthcare Ag Estabilidad mejorada de formulaciones de progestágenos
TWI547431B (zh) * 2004-06-09 2016-09-01 史密斯克萊美占公司 生產藥物之裝置及方法
US20060002986A1 (en) * 2004-06-09 2006-01-05 Smithkline Beecham Corporation Pharmaceutical product
US8715724B2 (en) * 2004-10-29 2014-05-06 Mayne Pharma International Pty Ltd Tabletting process
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
EP2040718B1 (en) * 2006-06-28 2017-12-27 Emisphere Technologies, Inc. Gallium nitrate formulations
CN101810706B (zh) * 2009-05-26 2011-03-16 成都地奥制药集团有限公司 一种低剂量地榆固体制剂的制备方法
US20170182070A1 (en) 2014-10-08 2017-06-29 Mayne Pharma International Pty Ltd. Controlled Release Doxycycline
EP3843889A1 (en) * 2018-08-30 2021-07-07 Boehringer Ingelheim International GmbH Novel, lean and environment-friendly granulation method
SG11202113359RA (en) 2019-07-01 2021-12-30 Oakwood Laboratories LLC System and method for making microspheres and emulsions
US11330838B2 (en) 2019-07-19 2022-05-17 R. J. Reynolds Tobacco Company Holder for aerosol delivery device with detachable cartridge

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300523B1 (en) * 1987-07-06 1991-08-14 Akzo N.V. Pharmaceutical dosage unit for the prevention or treatment of climacteric complaints
US5098714A (en) * 1989-11-16 1992-03-24 Alza Corporation Osmotic, oral dosage form for fertility control
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
WO1996009056A1 (en) * 1994-09-22 1996-03-28 Akzo Nobel N.V. Process of making dosage units by wet granulation
IL115445A (en) * 1994-10-17 1999-08-17 Akzo Nobel Nv Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation

Also Published As

Publication number Publication date
CZ88899A3 (cs) 1999-11-17
NO991195L (no) 1999-09-13
CA2265211A1 (en) 1999-09-12
JPH11319035A (ja) 1999-11-24
KR19990077775A (ko) 1999-10-25
HU9900598D0 (en) 1999-05-28
HUP9900598A2 (hu) 2001-06-28
NO991195D0 (no) 1999-03-11
CN1238948A (zh) 1999-12-22
AU2118199A (en) 1999-09-23
BR9904552A (pt) 2000-09-26
SG72938A1 (en) 2000-05-23
TR199900548A2 (tr) 1999-10-21
AR016454A1 (es) 2001-07-04
PL331961A1 (en) 1999-09-13
IL128818A0 (en) 2000-01-31
US6054145A (en) 2000-04-25

Similar Documents

Publication Publication Date Title
ID26420A (id) Indolinon-indolinon tersubstitusi baru, pembuatannya dan penggunaannya sebagai komposisi-komposisi farmasi
IS6624A (is) Samfelld framleiðsla á lyfjafræðilegri kornamyndun
MA26937A1 (fr) Nouvelle composition pharmaceutique.
TR199901077A3 (tr) Ispençiyari formülasyonlar.
ID26334A (id) Morfolinol yang aktif secara farmasi
DE69927803D1 (de) Imidazo-pyridin verbindungen, die die sekretion von magensäure hemmen.
MA25413A1 (fr) Fabrication de micromousse therapeutique.
ID27415A (id) Komposisi farmaseutik
DK1208864T3 (da) Forbedringer til lægemiddelafgivelsesindretninger
MA26812A1 (fr) Pyrimidine-2,4,6-triones inhibitrices de metalloproteinases
ID29262A (id) Komposisi farmasi
NO992692L (no) Nefadozon doseringsform
DK1466615T3 (da) Farmaceutisk præparat
TR199900548A3 (tr) Düsük kesme kuvvetli taneleme kullanilarak dozaj birimlerinin yapimi.
DZ3155A1 (fr) Nouvelle composition pharmaceutique.
NO994294D0 (no) Tablett til Õ svelge omfattende paracetamol
NO20005179D0 (no) Medikament behandling
IT1303694B1 (it) Produzione di perfluoroalchilvinileteri.
IS5600A (is) Aðferð til framleiðslu á vernduðu 4-amínómetýl-pýrrólidín-3-óni.
NO20010089D0 (no) Farmasöytisk levotyroksinpreparat
TR199801871A3 (tr) Bifenilsulfonilsiyanamidler üretim yöntemi ve ilaç olarak kullanimlari.
DZ3164A1 (fr) Nouvel agent pharmaceutique.
IT245517Y1 (it) Mescolatrice per impianti per la fabbricazione di blocchi di materialelapideo.
NO20021866L (no) Ciclesonid-inneholdende vandig farmasoytisk blanding
ATE283629T1 (de) Deltamethrinhaltiges, wasserdispergierbares granulat